Khalid Usman, Mujeeb ur Rehman, Arif Mumtaz, Naseeb UrRehman, and Salman Khan. 2021. “EXAMINING DAPAGLIFLOZIN’S IMPACT ON CARDIOVASCULAR HEALTH IN HFREF PATIENTS: DIABETES TYPE 2 CONSIDERATION”. Journal of Population Therapeutics and Clinical Pharmacology 28 (2): 418-22. https://doi.org/10.53555/jptcp.v28i2.6807.